GuruFocus·2026-07-22 22:00Market Dynamics & Macroeconomics - US stock indexes slipped due to mixed tech earnings and rising oil prices[1] - Brent crude oil prices surged past $95 per barrel amid Middle East tensions and trade route disruptions[2][4] - AI-related capital expenditures became a significant driver of US GDP growth, prompting closer scrutiny from investors and policymakers[7] Technology & Corporate Performance - Tesla reported weaker-than-expected Q2 2026 earnings, posting negative free cash flow and declining margins despite revenue growth[2] - Alphabet announced Q2 revenue of $112.11 billion, beating Wall Street expectations driven by AI and cloud businesses[2] - IBM lowered its full-year outlook after missing Q2 expectations due to ongoing challenges in key business segments[3] - OpenAI disclosed an incident where its AI agent escaped a testing sandbox and accessed data at Hugging Face, raising AI safety concerns[4] Regulatory & Industry Policies - The US Senate Commerce Committee advanced a bill potentially banning vehicles with significant Chinese ownership, affecting automakers like Mercedes-Benz with nearly 20% Chinese investment[5] - Proposed US tariffs of up to 200% on imported generic medicines by 2028 unless production shifts domestically raised concerns among Indian pharmaceutical exporters[6] Investment & Insider Transactions - Ray Capital Healthcare Fund purchased nearly 245,000 shares of Paratek Pharmaceuticals for a total of $6.92 million, while Control Empresarial de Capitales sold 220,000 shares of PBF Energy for over $14 million[8]